nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—SLC22A7—Pravastatin—atherosclerosis	0.118	0.157	CbGbCtD
Zalcitabine—SLC22A6—Pravastatin—atherosclerosis	0.0501	0.0668	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0467	0.0623	CbGbCtD
Zalcitabine—CYP3A7—Simvastatin—atherosclerosis	0.0467	0.0623	CbGbCtD
Zalcitabine—CYP3A7—Lovastatin—atherosclerosis	0.0457	0.061	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0457	0.061	CbGbCtD
Zalcitabine—CYP3A5—Rosuvastatin—atherosclerosis	0.0377	0.0503	CbGbCtD
Zalcitabine—CYP3A5—Simvastatin—atherosclerosis	0.035	0.0468	CbGbCtD
Zalcitabine—CYP3A5—Pravastatin—atherosclerosis	0.0343	0.0458	CbGbCtD
Zalcitabine—CYP3A5—Lovastatin—atherosclerosis	0.0343	0.0458	CbGbCtD
Zalcitabine—CYP2D6—Niacin—atherosclerosis	0.0272	0.0363	CbGbCtD
Zalcitabine—CYP2C9—Rosuvastatin—atherosclerosis	0.0253	0.0337	CbGbCtD
Zalcitabine—CYP2C9—Simvastatin—atherosclerosis	0.0235	0.0314	CbGbCtD
Zalcitabine—CYP2C9—Pravastatin—atherosclerosis	0.023	0.0307	CbGbCtD
Zalcitabine—CYP2C9—Lovastatin—atherosclerosis	0.023	0.0307	CbGbCtD
Zalcitabine—CYP2D6—Simvastatin—atherosclerosis	0.0215	0.0287	CbGbCtD
Zalcitabine—CYP2D6—Lovastatin—atherosclerosis	0.021	0.0281	CbGbCtD
Zalcitabine—CYP2D6—Pravastatin—atherosclerosis	0.021	0.0281	CbGbCtD
Zalcitabine—CYP3A4—Ezetimibe—atherosclerosis	0.0147	0.0196	CbGbCtD
Zalcitabine—CYP3A4—Rosuvastatin—atherosclerosis	0.0147	0.0196	CbGbCtD
Zalcitabine—CYP3A4—Simvastatin—atherosclerosis	0.0137	0.0182	CbGbCtD
Zalcitabine—CYP3A4—Pravastatin—atherosclerosis	0.0134	0.0178	CbGbCtD
Zalcitabine—CYP3A4—Lovastatin—atherosclerosis	0.0134	0.0178	CbGbCtD
Zalcitabine—DCK—Simvastatin—Pravastatin—atherosclerosis	0.00211	0.5	CbGdCrCtD
Zalcitabine—DCK—Simvastatin—Lovastatin—atherosclerosis	0.00211	0.5	CbGdCrCtD
Zalcitabine—Chills—Lovastatin—atherosclerosis	0.000396	0.0019	CcSEcCtD
Zalcitabine—Cough—Rosuvastatin—atherosclerosis	0.000395	0.0019	CcSEcCtD
Zalcitabine—Sinusitis—Pravastatin—atherosclerosis	0.00039	0.00187	CcSEcCtD
Zalcitabine—Alopecia—Lovastatin—atherosclerosis	0.00039	0.00187	CcSEcCtD
Zalcitabine—Myalgia—Rosuvastatin—atherosclerosis	0.000386	0.00185	CcSEcCtD
Zalcitabine—Arthralgia—Rosuvastatin—atherosclerosis	0.000386	0.00185	CcSEcCtD
Zalcitabine—Flushing—Simvastatin—atherosclerosis	0.000383	0.00184	CcSEcCtD
Zalcitabine—Alopecia—Ezetimibe—atherosclerosis	0.000382	0.00184	CcSEcCtD
Zalcitabine—Rhinitis—Niacin—atherosclerosis	0.00038	0.00182	CcSEcCtD
Zalcitabine—Hepatitis—Niacin—atherosclerosis	0.000379	0.00182	CcSEcCtD
Zalcitabine—Flatulence—Lovastatin—atherosclerosis	0.000378	0.00182	CcSEcCtD
Zalcitabine—Dysgeusia—Lovastatin—atherosclerosis	0.000376	0.00181	CcSEcCtD
Zalcitabine—Rhinitis—Pravastatin—atherosclerosis	0.000374	0.0018	CcSEcCtD
Zalcitabine—Hepatitis—Pravastatin—atherosclerosis	0.000373	0.00179	CcSEcCtD
Zalcitabine—Confusional state—Rosuvastatin—atherosclerosis	0.000373	0.00179	CcSEcCtD
Zalcitabine—Back pain—Lovastatin—atherosclerosis	0.000371	0.00178	CcSEcCtD
Zalcitabine—Flatulence—Ezetimibe—atherosclerosis	0.000371	0.00178	CcSEcCtD
Zalcitabine—Pharyngitis—Pravastatin—atherosclerosis	0.00037	0.00178	CcSEcCtD
Zalcitabine—Chills—Simvastatin—atherosclerosis	0.00037	0.00178	CcSEcCtD
Zalcitabine—Muscle spasms—Lovastatin—atherosclerosis	0.000369	0.00177	CcSEcCtD
Zalcitabine—Infection—Rosuvastatin—atherosclerosis	0.000367	0.00176	CcSEcCtD
Zalcitabine—Visual impairment—Niacin—atherosclerosis	0.000365	0.00175	CcSEcCtD
Zalcitabine—Alopecia—Simvastatin—atherosclerosis	0.000365	0.00175	CcSEcCtD
Zalcitabine—Back pain—Ezetimibe—atherosclerosis	0.000364	0.00175	CcSEcCtD
Zalcitabine—Muscle spasms—Ezetimibe—atherosclerosis	0.000362	0.00174	CcSEcCtD
Zalcitabine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000362	0.00174	CcSEcCtD
Zalcitabine—Vision blurred—Lovastatin—atherosclerosis	0.000362	0.00174	CcSEcCtD
Zalcitabine—Tremor—Lovastatin—atherosclerosis	0.00036	0.00173	CcSEcCtD
Zalcitabine—Visual impairment—Pravastatin—atherosclerosis	0.000359	0.00173	CcSEcCtD
Zalcitabine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000356	0.00171	CcSEcCtD
Zalcitabine—Eye disorder—Niacin—atherosclerosis	0.000354	0.0017	CcSEcCtD
Zalcitabine—Flatulence—Simvastatin—atherosclerosis	0.000354	0.0017	CcSEcCtD
Zalcitabine—Tinnitus—Niacin—atherosclerosis	0.000353	0.0017	CcSEcCtD
Zalcitabine—Dysgeusia—Simvastatin—atherosclerosis	0.000352	0.00169	CcSEcCtD
Zalcitabine—Flushing—Niacin—atherosclerosis	0.000352	0.00169	CcSEcCtD
Zalcitabine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000349	0.00168	CcSEcCtD
Zalcitabine—Anaemia—Ezetimibe—atherosclerosis	0.000348	0.00167	CcSEcCtD
Zalcitabine—Tinnitus—Pravastatin—atherosclerosis	0.000348	0.00167	CcSEcCtD
Zalcitabine—Malaise—Lovastatin—atherosclerosis	0.000346	0.00166	CcSEcCtD
Zalcitabine—Flushing—Pravastatin—atherosclerosis	0.000346	0.00166	CcSEcCtD
Zalcitabine—Muscle spasms—Simvastatin—atherosclerosis	0.000345	0.00166	CcSEcCtD
Zalcitabine—Vertigo—Lovastatin—atherosclerosis	0.000345	0.00166	CcSEcCtD
Zalcitabine—Leukopenia—Lovastatin—atherosclerosis	0.000344	0.00165	CcSEcCtD
Zalcitabine—Chills—Niacin—atherosclerosis	0.00034	0.00163	CcSEcCtD
Zalcitabine—Malaise—Ezetimibe—atherosclerosis	0.00034	0.00163	CcSEcCtD
Zalcitabine—Vision blurred—Simvastatin—atherosclerosis	0.000338	0.00162	CcSEcCtD
Zalcitabine—Arrhythmia—Niacin—atherosclerosis	0.000338	0.00162	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000337	0.00162	CcSEcCtD
Zalcitabine—Tremor—Simvastatin—atherosclerosis	0.000336	0.00162	CcSEcCtD
Zalcitabine—Alopecia—Niacin—atherosclerosis	0.000335	0.00161	CcSEcCtD
Zalcitabine—Chills—Pravastatin—atherosclerosis	0.000335	0.00161	CcSEcCtD
Zalcitabine—Insomnia—Rosuvastatin—atherosclerosis	0.000334	0.00161	CcSEcCtD
Zalcitabine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000333	0.0016	CcSEcCtD
Zalcitabine—Arrhythmia—Pravastatin—atherosclerosis	0.000333	0.0016	CcSEcCtD
Zalcitabine—Palpitations—Ezetimibe—atherosclerosis	0.000333	0.0016	CcSEcCtD
Zalcitabine—Anaemia—Simvastatin—atherosclerosis	0.000332	0.00159	CcSEcCtD
Zalcitabine—Alopecia—Pravastatin—atherosclerosis	0.00033	0.00158	CcSEcCtD
Zalcitabine—Cough—Ezetimibe—atherosclerosis	0.000329	0.00158	CcSEcCtD
Zalcitabine—Arthralgia—Lovastatin—atherosclerosis	0.000327	0.00157	CcSEcCtD
Zalcitabine—Myalgia—Lovastatin—atherosclerosis	0.000327	0.00157	CcSEcCtD
Zalcitabine—Anxiety—Lovastatin—atherosclerosis	0.000326	0.00156	CcSEcCtD
Zalcitabine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000325	0.00156	CcSEcCtD
Zalcitabine—Hypertension—Ezetimibe—atherosclerosis	0.000325	0.00156	CcSEcCtD
Zalcitabine—Flatulence—Niacin—atherosclerosis	0.000325	0.00156	CcSEcCtD
Zalcitabine—Malaise—Simvastatin—atherosclerosis	0.000324	0.00155	CcSEcCtD
Zalcitabine—Tension—Niacin—atherosclerosis	0.000324	0.00155	CcSEcCtD
Zalcitabine—Discomfort—Lovastatin—atherosclerosis	0.000323	0.00155	CcSEcCtD
Zalcitabine—Vertigo—Simvastatin—atherosclerosis	0.000323	0.00155	CcSEcCtD
Zalcitabine—Leukopenia—Simvastatin—atherosclerosis	0.000321	0.00154	CcSEcCtD
Zalcitabine—Arthralgia—Ezetimibe—atherosclerosis	0.000321	0.00154	CcSEcCtD
Zalcitabine—Myalgia—Ezetimibe—atherosclerosis	0.000321	0.00154	CcSEcCtD
Zalcitabine—Nervousness—Niacin—atherosclerosis	0.00032	0.00154	CcSEcCtD
Zalcitabine—Flatulence—Pravastatin—atherosclerosis	0.00032	0.00154	CcSEcCtD
Zalcitabine—Dry mouth—Lovastatin—atherosclerosis	0.00032	0.00153	CcSEcCtD
Zalcitabine—Tension—Pravastatin—atherosclerosis	0.000319	0.00153	CcSEcCtD
Zalcitabine—Dysgeusia—Pravastatin—atherosclerosis	0.000318	0.00153	CcSEcCtD
Zalcitabine—Muscle spasms—Niacin—atherosclerosis	0.000317	0.00152	CcSEcCtD
Zalcitabine—Discomfort—Ezetimibe—atherosclerosis	0.000317	0.00152	CcSEcCtD
Zalcitabine—Pain—Rosuvastatin—atherosclerosis	0.000316	0.00152	CcSEcCtD
Zalcitabine—Confusional state—Lovastatin—atherosclerosis	0.000316	0.00152	CcSEcCtD
Zalcitabine—Nervousness—Pravastatin—atherosclerosis	0.000315	0.00151	CcSEcCtD
Zalcitabine—Dry mouth—Ezetimibe—atherosclerosis	0.000314	0.00151	CcSEcCtD
Zalcitabine—Muscle spasms—Pravastatin—atherosclerosis	0.000312	0.0015	CcSEcCtD
Zalcitabine—Infection—Lovastatin—atherosclerosis	0.000311	0.00149	CcSEcCtD
Zalcitabine—Vision blurred—Niacin—atherosclerosis	0.000311	0.00149	CcSEcCtD
Zalcitabine—Confusional state—Ezetimibe—atherosclerosis	0.00031	0.00149	CcSEcCtD
Zalcitabine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000307	0.00147	CcSEcCtD
Zalcitabine—Vision blurred—Pravastatin—atherosclerosis	0.000306	0.00147	CcSEcCtD
Zalcitabine—Myalgia—Simvastatin—atherosclerosis	0.000306	0.00147	CcSEcCtD
Zalcitabine—Arthralgia—Simvastatin—atherosclerosis	0.000306	0.00147	CcSEcCtD
Zalcitabine—Infection—Ezetimibe—atherosclerosis	0.000305	0.00147	CcSEcCtD
Zalcitabine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000305	0.00146	CcSEcCtD
Zalcitabine—Anxiety—Simvastatin—atherosclerosis	0.000305	0.00146	CcSEcCtD
Zalcitabine—Tremor—Pravastatin—atherosclerosis	0.000304	0.00146	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000302	0.00145	CcSEcCtD
Zalcitabine—Discomfort—Simvastatin—atherosclerosis	0.000302	0.00145	CcSEcCtD
Zalcitabine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000301	0.00145	CcSEcCtD
Zalcitabine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000301	0.00144	CcSEcCtD
Zalcitabine—Anaemia—Pravastatin—atherosclerosis	0.0003	0.00144	CcSEcCtD
Zalcitabine—Anorexia—Lovastatin—atherosclerosis	0.000299	0.00143	CcSEcCtD
Zalcitabine—Skin disorder—Ezetimibe—atherosclerosis	0.000298	0.00143	CcSEcCtD
Zalcitabine—Vertigo—Niacin—atherosclerosis	0.000296	0.00142	CcSEcCtD
Zalcitabine—Syncope—Niacin—atherosclerosis	0.000296	0.00142	CcSEcCtD
Zalcitabine—Confusional state—Simvastatin—atherosclerosis	0.000295	0.00142	CcSEcCtD
Zalcitabine—Leukopenia—Niacin—atherosclerosis	0.000295	0.00142	CcSEcCtD
Zalcitabine—Urticaria—Rosuvastatin—atherosclerosis	0.000294	0.00141	CcSEcCtD
Zalcitabine—Oedema—Simvastatin—atherosclerosis	0.000293	0.00141	CcSEcCtD
Zalcitabine—Malaise—Pravastatin—atherosclerosis	0.000293	0.00141	CcSEcCtD
Zalcitabine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000292	0.0014	CcSEcCtD
Zalcitabine—Vertigo—Pravastatin—atherosclerosis	0.000292	0.0014	CcSEcCtD
Zalcitabine—Palpitations—Niacin—atherosclerosis	0.000291	0.0014	CcSEcCtD
Zalcitabine—Infection—Simvastatin—atherosclerosis	0.000291	0.0014	CcSEcCtD
Zalcitabine—Leukopenia—Pravastatin—atherosclerosis	0.000291	0.0014	CcSEcCtD
Zalcitabine—Loss of consciousness—Niacin—atherosclerosis	0.00029	0.00139	CcSEcCtD
Zalcitabine—Cough—Niacin—atherosclerosis	0.000288	0.00138	CcSEcCtD
Zalcitabine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000287	0.00138	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000285	0.00137	CcSEcCtD
Zalcitabine—Insomnia—Lovastatin—atherosclerosis	0.000283	0.00136	CcSEcCtD
Zalcitabine—Cough—Pravastatin—atherosclerosis	0.000283	0.00136	CcSEcCtD
Zalcitabine—Myalgia—Niacin—atherosclerosis	0.000281	0.00135	CcSEcCtD
Zalcitabine—Arthralgia—Niacin—atherosclerosis	0.000281	0.00135	CcSEcCtD
Zalcitabine—Hypertension—Pravastatin—atherosclerosis	0.00028	0.00135	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00028	0.00134	CcSEcCtD
Zalcitabine—Anorexia—Simvastatin—atherosclerosis	0.000279	0.00134	CcSEcCtD
Zalcitabine—Dyspnoea—Lovastatin—atherosclerosis	0.000279	0.00134	CcSEcCtD
Zalcitabine—Insomnia—Ezetimibe—atherosclerosis	0.000278	0.00133	CcSEcCtD
Zalcitabine—Arthralgia—Pravastatin—atherosclerosis	0.000276	0.00133	CcSEcCtD
Zalcitabine—Myalgia—Pravastatin—atherosclerosis	0.000276	0.00133	CcSEcCtD
Zalcitabine—Dyspepsia—Lovastatin—atherosclerosis	0.000276	0.00132	CcSEcCtD
Zalcitabine—Anxiety—Pravastatin—atherosclerosis	0.000275	0.00132	CcSEcCtD
Zalcitabine—Dry mouth—Niacin—atherosclerosis	0.000275	0.00132	CcSEcCtD
Zalcitabine—Dyspnoea—Ezetimibe—atherosclerosis	0.000274	0.00132	CcSEcCtD
Zalcitabine—Discomfort—Pravastatin—atherosclerosis	0.000273	0.00131	CcSEcCtD
Zalcitabine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000272	0.00131	CcSEcCtD
Zalcitabine—Decreased appetite—Lovastatin—atherosclerosis	0.000272	0.00131	CcSEcCtD
Zalcitabine—Dyspepsia—Ezetimibe—atherosclerosis	0.000271	0.0013	CcSEcCtD
Zalcitabine—Fatigue—Lovastatin—atherosclerosis	0.00027	0.0013	CcSEcCtD
Zalcitabine—Oedema—Niacin—atherosclerosis	0.000269	0.00129	CcSEcCtD
Zalcitabine—Pain—Lovastatin—atherosclerosis	0.000268	0.00129	CcSEcCtD
Zalcitabine—Confusional state—Pravastatin—atherosclerosis	0.000267	0.00128	CcSEcCtD
Zalcitabine—Decreased appetite—Ezetimibe—atherosclerosis	0.000267	0.00128	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000267	0.00128	CcSEcCtD
Zalcitabine—Asthenia—Rosuvastatin—atherosclerosis	0.000265	0.00127	CcSEcCtD
Zalcitabine—Insomnia—Simvastatin—atherosclerosis	0.000265	0.00127	CcSEcCtD
Zalcitabine—Oedema—Pravastatin—atherosclerosis	0.000265	0.00127	CcSEcCtD
Zalcitabine—Fatigue—Ezetimibe—atherosclerosis	0.000265	0.00127	CcSEcCtD
Zalcitabine—Shock—Niacin—atherosclerosis	0.000265	0.00127	CcSEcCtD
Zalcitabine—Infection—Pravastatin—atherosclerosis	0.000263	0.00126	CcSEcCtD
Zalcitabine—Pain—Ezetimibe—atherosclerosis	0.000263	0.00126	CcSEcCtD
Zalcitabine—Tachycardia—Niacin—atherosclerosis	0.000263	0.00126	CcSEcCtD
Zalcitabine—Pruritus—Rosuvastatin—atherosclerosis	0.000262	0.00126	CcSEcCtD
Zalcitabine—Skin disorder—Niacin—atherosclerosis	0.000261	0.00125	CcSEcCtD
Zalcitabine—Dyspnoea—Simvastatin—atherosclerosis	0.000261	0.00125	CcSEcCtD
Zalcitabine—Hyperhidrosis—Niacin—atherosclerosis	0.00026	0.00125	CcSEcCtD
Zalcitabine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000259	0.00125	CcSEcCtD
Zalcitabine—Feeling abnormal—Lovastatin—atherosclerosis	0.000258	0.00124	CcSEcCtD
Zalcitabine—Dyspepsia—Simvastatin—atherosclerosis	0.000258	0.00124	CcSEcCtD
Zalcitabine—Anorexia—Niacin—atherosclerosis	0.000257	0.00123	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000256	0.00123	CcSEcCtD
Zalcitabine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000256	0.00123	CcSEcCtD
Zalcitabine—Decreased appetite—Simvastatin—atherosclerosis	0.000255	0.00122	CcSEcCtD
Zalcitabine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000253	0.00122	CcSEcCtD
Zalcitabine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000253	0.00121	CcSEcCtD
Zalcitabine—Fatigue—Simvastatin—atherosclerosis	0.000253	0.00121	CcSEcCtD
Zalcitabine—Anorexia—Pravastatin—atherosclerosis	0.000253	0.00121	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000251	0.00121	CcSEcCtD
Zalcitabine—Pain—Simvastatin—atherosclerosis	0.000251	0.0012	CcSEcCtD
Zalcitabine—Urticaria—Lovastatin—atherosclerosis	0.000249	0.0012	CcSEcCtD
Zalcitabine—Abdominal pain—Lovastatin—atherosclerosis	0.000248	0.00119	CcSEcCtD
Zalcitabine—Body temperature increased—Lovastatin—atherosclerosis	0.000248	0.00119	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000245	0.00118	CcSEcCtD
Zalcitabine—Dizziness—Rosuvastatin—atherosclerosis	0.000244	0.00117	CcSEcCtD
Zalcitabine—Urticaria—Ezetimibe—atherosclerosis	0.000244	0.00117	CcSEcCtD
Zalcitabine—Insomnia—Niacin—atherosclerosis	0.000243	0.00117	CcSEcCtD
Zalcitabine—Abdominal pain—Ezetimibe—atherosclerosis	0.000243	0.00117	CcSEcCtD
Zalcitabine—Body temperature increased—Ezetimibe—atherosclerosis	0.000243	0.00117	CcSEcCtD
Zalcitabine—Feeling abnormal—Simvastatin—atherosclerosis	0.000242	0.00116	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000241	0.00116	CcSEcCtD
Zalcitabine—Dyspnoea—Niacin—atherosclerosis	0.00024	0.00115	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00024	0.00115	CcSEcCtD
Zalcitabine—Insomnia—Pravastatin—atherosclerosis	0.00024	0.00115	CcSEcCtD
Zalcitabine—Somnolence—Niacin—atherosclerosis	0.000239	0.00115	CcSEcCtD
Zalcitabine—Dyspepsia—Niacin—atherosclerosis	0.000237	0.00114	CcSEcCtD
Zalcitabine—Dyspnoea—Pravastatin—atherosclerosis	0.000236	0.00113	CcSEcCtD
Zalcitabine—Decreased appetite—Niacin—atherosclerosis	0.000234	0.00112	CcSEcCtD
Zalcitabine—Dyspepsia—Pravastatin—atherosclerosis	0.000233	0.00112	CcSEcCtD
Zalcitabine—Rash—Rosuvastatin—atherosclerosis	0.000233	0.00112	CcSEcCtD
Zalcitabine—Dermatitis—Rosuvastatin—atherosclerosis	0.000233	0.00112	CcSEcCtD
Zalcitabine—Urticaria—Simvastatin—atherosclerosis	0.000233	0.00112	CcSEcCtD
Zalcitabine—Body temperature increased—Simvastatin—atherosclerosis	0.000232	0.00111	CcSEcCtD
Zalcitabine—Abdominal pain—Simvastatin—atherosclerosis	0.000232	0.00111	CcSEcCtD
Zalcitabine—Headache—Rosuvastatin—atherosclerosis	0.000232	0.00111	CcSEcCtD
Zalcitabine—Hypersensitivity—Lovastatin—atherosclerosis	0.000231	0.00111	CcSEcCtD
Zalcitabine—Decreased appetite—Pravastatin—atherosclerosis	0.00023	0.00111	CcSEcCtD
Zalcitabine—Pain—Niacin—atherosclerosis	0.00023	0.0011	CcSEcCtD
Zalcitabine—Fatigue—Pravastatin—atherosclerosis	0.000228	0.0011	CcSEcCtD
Zalcitabine—Pain—Pravastatin—atherosclerosis	0.000227	0.00109	CcSEcCtD
Zalcitabine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000226	0.00109	CcSEcCtD
Zalcitabine—Asthenia—Lovastatin—atherosclerosis	0.000225	0.00108	CcSEcCtD
Zalcitabine—Pruritus—Lovastatin—atherosclerosis	0.000222	0.00106	CcSEcCtD
Zalcitabine—Asthenia—Ezetimibe—atherosclerosis	0.00022	0.00106	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Niacin—atherosclerosis	0.00022	0.00106	CcSEcCtD
Zalcitabine—Feeling abnormal—Pravastatin—atherosclerosis	0.000218	0.00105	CcSEcCtD
Zalcitabine—Pruritus—Ezetimibe—atherosclerosis	0.000217	0.00104	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000217	0.00104	CcSEcCtD
Zalcitabine—Hypersensitivity—Simvastatin—atherosclerosis	0.000216	0.00104	CcSEcCtD
Zalcitabine—Diarrhoea—Lovastatin—atherosclerosis	0.000214	0.00103	CcSEcCtD
Zalcitabine—Urticaria—Niacin—atherosclerosis	0.000214	0.00103	CcSEcCtD
Zalcitabine—Abdominal pain—Niacin—atherosclerosis	0.000213	0.00102	CcSEcCtD
Zalcitabine—Body temperature increased—Niacin—atherosclerosis	0.000213	0.00102	CcSEcCtD
Zalcitabine—Urticaria—Pravastatin—atherosclerosis	0.00021	0.00101	CcSEcCtD
Zalcitabine—Asthenia—Simvastatin—atherosclerosis	0.00021	0.00101	CcSEcCtD
Zalcitabine—Diarrhoea—Ezetimibe—atherosclerosis	0.00021	0.00101	CcSEcCtD
Zalcitabine—Abdominal pain—Pravastatin—atherosclerosis	0.000209	0.00101	CcSEcCtD
Zalcitabine—Body temperature increased—Pravastatin—atherosclerosis	0.000209	0.00101	CcSEcCtD
Zalcitabine—Pruritus—Simvastatin—atherosclerosis	0.000207	0.000996	CcSEcCtD
Zalcitabine—Dizziness—Lovastatin—atherosclerosis	0.000207	0.000995	CcSEcCtD
Zalcitabine—Dizziness—Ezetimibe—atherosclerosis	0.000203	0.000976	CcSEcCtD
Zalcitabine—Diarrhoea—Simvastatin—atherosclerosis	0.000201	0.000963	CcSEcCtD
Zalcitabine—Vomiting—Lovastatin—atherosclerosis	0.000199	0.000956	CcSEcCtD
Zalcitabine—Hypersensitivity—Niacin—atherosclerosis	0.000198	0.000952	CcSEcCtD
Zalcitabine—Rash—Lovastatin—atherosclerosis	0.000198	0.000949	CcSEcCtD
Zalcitabine—Dermatitis—Lovastatin—atherosclerosis	0.000197	0.000948	CcSEcCtD
Zalcitabine—Headache—Lovastatin—atherosclerosis	0.000196	0.000942	CcSEcCtD
Zalcitabine—Vomiting—Ezetimibe—atherosclerosis	0.000195	0.000938	CcSEcCtD
Zalcitabine—Hypersensitivity—Pravastatin—atherosclerosis	0.000195	0.000937	CcSEcCtD
Zalcitabine—Dizziness—Simvastatin—atherosclerosis	0.000194	0.00093	CcSEcCtD
Zalcitabine—Rash—Ezetimibe—atherosclerosis	0.000194	0.00093	CcSEcCtD
Zalcitabine—Dermatitis—Ezetimibe—atherosclerosis	0.000194	0.000929	CcSEcCtD
Zalcitabine—Asthenia—Niacin—atherosclerosis	0.000193	0.000927	CcSEcCtD
Zalcitabine—Headache—Ezetimibe—atherosclerosis	0.000193	0.000924	CcSEcCtD
Zalcitabine—Pruritus—Niacin—atherosclerosis	0.00019	0.000914	CcSEcCtD
Zalcitabine—Asthenia—Pravastatin—atherosclerosis	0.00019	0.000913	CcSEcCtD
Zalcitabine—Pruritus—Pravastatin—atherosclerosis	0.000187	0.0009	CcSEcCtD
Zalcitabine—Vomiting—Simvastatin—atherosclerosis	0.000186	0.000895	CcSEcCtD
Zalcitabine—Rash—Simvastatin—atherosclerosis	0.000185	0.000887	CcSEcCtD
Zalcitabine—Dermatitis—Simvastatin—atherosclerosis	0.000185	0.000886	CcSEcCtD
Zalcitabine—Diarrhoea—Niacin—atherosclerosis	0.000184	0.000884	CcSEcCtD
Zalcitabine—Headache—Simvastatin—atherosclerosis	0.000184	0.000881	CcSEcCtD
Zalcitabine—Diarrhoea—Pravastatin—atherosclerosis	0.000181	0.00087	CcSEcCtD
Zalcitabine—Dizziness—Niacin—atherosclerosis	0.000178	0.000854	CcSEcCtD
Zalcitabine—Dizziness—Pravastatin—atherosclerosis	0.000175	0.000841	CcSEcCtD
Zalcitabine—Vomiting—Niacin—atherosclerosis	0.000171	0.000821	CcSEcCtD
Zalcitabine—Rash—Niacin—atherosclerosis	0.00017	0.000815	CcSEcCtD
Zalcitabine—Dermatitis—Niacin—atherosclerosis	0.00017	0.000814	CcSEcCtD
Zalcitabine—Headache—Niacin—atherosclerosis	0.000169	0.000809	CcSEcCtD
Zalcitabine—Vomiting—Pravastatin—atherosclerosis	0.000168	0.000809	CcSEcCtD
Zalcitabine—Rash—Pravastatin—atherosclerosis	0.000167	0.000802	CcSEcCtD
Zalcitabine—Dermatitis—Pravastatin—atherosclerosis	0.000167	0.000801	CcSEcCtD
Zalcitabine—Headache—Pravastatin—atherosclerosis	0.000166	0.000797	CcSEcCtD
Zalcitabine—CYP2D6—Metabolism—PLTP—atherosclerosis	2.07e-05	0.000538	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PLTP—atherosclerosis	2.05e-05	0.000533	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	2.03e-05	0.000527	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—BGN—atherosclerosis	2.02e-05	0.000526	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—APOA5—atherosclerosis	2e-05	0.000521	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	2e-05	0.00052	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ABCG1—atherosclerosis	1.99e-05	0.000518	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PIK3CG—atherosclerosis	1.93e-05	0.000502	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PLA2G1B—atherosclerosis	1.93e-05	0.000501	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PIK3CG—atherosclerosis	1.9e-05	0.000495	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	1.9e-05	0.000494	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	1.89e-05	0.000491	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	1.87e-05	0.000488	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—LCAT—atherosclerosis	1.87e-05	0.000487	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—FABP4—atherosclerosis	1.87e-05	0.000487	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PPARG—atherosclerosis	1.86e-05	0.000485	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ALOX5—atherosclerosis	1.86e-05	0.000484	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—APOA4—atherosclerosis	1.84e-05	0.000478	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PPARG—atherosclerosis	1.83e-05	0.000477	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	1.83e-05	0.000476	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—INS—atherosclerosis	1.83e-05	0.000475	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP7A1—atherosclerosis	1.81e-05	0.00047	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—INS—atherosclerosis	1.8e-05	0.000468	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—LTA4H—atherosclerosis	1.79e-05	0.000466	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ABCG8—atherosclerosis	1.79e-05	0.000466	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—LTA4H—atherosclerosis	1.78e-05	0.000462	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ABCG8—atherosclerosis	1.78e-05	0.000462	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	1.75e-05	0.000456	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—ALB—atherosclerosis	1.7e-05	0.000442	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ALB—atherosclerosis	1.67e-05	0.000436	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—NAMPT—atherosclerosis	1.67e-05	0.000434	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP27A1—atherosclerosis	1.67e-05	0.000434	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—LIPC—atherosclerosis	1.66e-05	0.000432	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.66e-05	0.000431	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ALB—atherosclerosis	1.65e-05	0.000429	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—APOC3—atherosclerosis	1.65e-05	0.000429	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—LDLR—atherosclerosis	1.64e-05	0.000426	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—NOS3—atherosclerosis	1.6e-05	0.000417	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CETP—atherosclerosis	1.6e-05	0.000416	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—APOA2—atherosclerosis	1.58e-05	0.000412	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PLA2G2A—atherosclerosis	1.58e-05	0.000412	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALOX5AP—atherosclerosis	1.58e-05	0.000412	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALOX15—atherosclerosis	1.58e-05	0.000412	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—NOS3—atherosclerosis	1.58e-05	0.000411	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ABCG5—atherosclerosis	1.56e-05	0.000407	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—SCARB1—atherosclerosis	1.53e-05	0.000399	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—LPA—atherosclerosis	1.51e-05	0.000393	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.48e-05	0.000384	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PTGS2—atherosclerosis	1.47e-05	0.000381	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—BGN—atherosclerosis	1.46e-05	0.00038	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—HMGCR—atherosclerosis	1.45e-05	0.000377	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—APOA5—atherosclerosis	1.45e-05	0.000376	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PTGS2—atherosclerosis	1.44e-05	0.000376	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	1.44e-05	0.000374	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ABCG1—atherosclerosis	1.42e-05	0.000368	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ABCG1—atherosclerosis	1.4e-05	0.000365	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PLA2G1B—atherosclerosis	1.39e-05	0.000362	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PLTP—atherosclerosis	1.35e-05	0.000351	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALOX5—atherosclerosis	1.34e-05	0.00035	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—FABP4—atherosclerosis	1.33e-05	0.000346	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—LCAT—atherosclerosis	1.33e-05	0.000346	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—FABP4—atherosclerosis	1.32e-05	0.000343	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—LCAT—atherosclerosis	1.32e-05	0.000343	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—APOA4—atherosclerosis	1.31e-05	0.00034	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—APOA4—atherosclerosis	1.3e-05	0.000337	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ABCA1—atherosclerosis	1.29e-05	0.000336	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP7A1—atherosclerosis	1.28e-05	0.000334	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP7A1—atherosclerosis	1.27e-05	0.000331	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.21e-05	0.000316	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NAMPT—atherosclerosis	1.21e-05	0.000314	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—LIPC—atherosclerosis	1.2e-05	0.000312	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—APOC3—atherosclerosis	1.19e-05	0.00031	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP27A1—atherosclerosis	1.19e-05	0.000309	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—LDLR—atherosclerosis	1.18e-05	0.000308	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.18e-05	0.000306	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.17e-05	0.000305	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.17e-05	0.000305	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.16e-05	0.000301	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CETP—atherosclerosis	1.16e-05	0.000301	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.13e-05	0.000294	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—APOA2—atherosclerosis	1.12e-05	0.000293	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.12e-05	0.000293	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.12e-05	0.000293	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.12e-05	0.000293	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.12e-05	0.00029	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—APOA2—atherosclerosis	1.12e-05	0.00029	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.12e-05	0.00029	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.12e-05	0.00029	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.11e-05	0.000289	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—SCARB1—atherosclerosis	1.11e-05	0.000288	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—HMOX1—atherosclerosis	1.11e-05	0.000288	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.1e-05	0.000287	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.1e-05	0.000286	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—LPA—atherosclerosis	1.07e-05	0.000279	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—LPA—atherosclerosis	1.06e-05	0.000277	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—APOB—atherosclerosis	1.06e-05	0.000276	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.05e-05	0.000272	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—BGN—atherosclerosis	1.04e-05	0.00027	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTM1—atherosclerosis	1.03e-05	0.000268	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—BGN—atherosclerosis	1.03e-05	0.000268	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—APOA5—atherosclerosis	1.03e-05	0.000268	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.02e-05	0.000266	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—APOA5—atherosclerosis	1.02e-05	0.000265	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—LPL—atherosclerosis	1.01e-05	0.000263	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	9.91e-06	0.000258	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	9.9e-06	0.000258	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GPX1—atherosclerosis	9.87e-06	0.000257	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	9.82e-06	0.000255	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	9.71e-06	0.000253	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	9.62e-06	0.00025	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CD36—atherosclerosis	9.62e-06	0.00025	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	9.59e-06	0.00025	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALOX5—atherosclerosis	9.56e-06	0.000249	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALOX5—atherosclerosis	9.48e-06	0.000247	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ABCA1—atherosclerosis	9.32e-06	0.000243	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCG1—atherosclerosis	9.26e-06	0.000241	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—MTHFR—atherosclerosis	9.11e-06	0.000237	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PPARA—atherosclerosis	8.94e-06	0.000233	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.76e-06	0.000228	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—FABP4—atherosclerosis	8.7e-06	0.000226	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—LCAT—atherosclerosis	8.7e-06	0.000226	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—AGT—atherosclerosis	8.66e-06	0.000225	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NAMPT—atherosclerosis	8.58e-06	0.000223	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—APOA4—atherosclerosis	8.54e-06	0.000222	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—LIPC—atherosclerosis	8.52e-06	0.000222	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NAMPT—atherosclerosis	8.5e-06	0.000221	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—APOE—atherosclerosis	8.48e-06	0.000221	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—APOC3—atherosclerosis	8.47e-06	0.00022	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.45e-06	0.00022	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—LIPC—atherosclerosis	8.45e-06	0.00022	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—LDLR—atherosclerosis	8.42e-06	0.000219	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CAV1—atherosclerosis	8.4e-06	0.000219	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—APOC3—atherosclerosis	8.4e-06	0.000219	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	8.39e-06	0.000218	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—APOA1—atherosclerosis	8.39e-06	0.000218	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—LDLR—atherosclerosis	8.35e-06	0.000217	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CETP—atherosclerosis	8.22e-06	0.000214	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CETP—atherosclerosis	8.15e-06	0.000212	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—HMOX1—atherosclerosis	8e-06	0.000208	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—SCARB1—atherosclerosis	7.88e-06	0.000205	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—SCARB1—atherosclerosis	7.81e-06	0.000203	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	7.76e-06	0.000202	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—APOB—atherosclerosis	7.66e-06	0.000199	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PIK3CG—atherosclerosis	7.66e-06	0.000199	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.6e-06	0.000198	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTM1—atherosclerosis	7.45e-06	0.000194	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HMGCR—atherosclerosis	7.44e-06	0.000194	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PPARG—atherosclerosis	7.39e-06	0.000192	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HMGCR—atherosclerosis	7.37e-06	0.000192	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—AKT1—atherosclerosis	7.36e-06	0.000192	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	7.35e-06	0.000191	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—APOA2—atherosclerosis	7.35e-06	0.000191	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	7.35e-06	0.000191	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALOX15—atherosclerosis	7.35e-06	0.000191	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—LPL—atherosclerosis	7.32e-06	0.00019	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCG5—atherosclerosis	7.26e-06	0.000189	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—AKT1—atherosclerosis	7.25e-06	0.000189	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—INS—atherosclerosis	7.25e-06	0.000189	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GPX1—atherosclerosis	7.14e-06	0.000186	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—LPA—atherosclerosis	7.02e-06	0.000183	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CD36—atherosclerosis	6.95e-06	0.000181	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—BGN—atherosclerosis	6.79e-06	0.000177	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—APOA5—atherosclerosis	6.73e-06	0.000175	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.65e-06	0.000173	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ALB—atherosclerosis	6.64e-06	0.000173	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ABCA1—atherosclerosis	6.63e-06	0.000173	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—MTHFR—atherosclerosis	6.59e-06	0.000171	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ABCA1—atherosclerosis	6.57e-06	0.000171	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.47e-06	0.000168	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PPARA—atherosclerosis	6.46e-06	0.000168	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—NOS3—atherosclerosis	6.36e-06	0.000165	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AGT—atherosclerosis	6.26e-06	0.000163	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.25e-06	0.000163	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—APOE—atherosclerosis	6.13e-06	0.00016	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CAV1—atherosclerosis	6.08e-06	0.000158	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—APOA1—atherosclerosis	6.06e-06	0.000158	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PTGS2—atherosclerosis	5.81e-06	0.000151	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HMOX1—atherosclerosis	5.69e-06	0.000148	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HMOX1—atherosclerosis	5.64e-06	0.000147	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.61e-06	0.000146	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—LIPC—atherosclerosis	5.57e-06	0.000145	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—APOC3—atherosclerosis	5.54e-06	0.000144	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PIK3CG—atherosclerosis	5.53e-06	0.000144	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—LDLR—atherosclerosis	5.5e-06	0.000143	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—APOB—atherosclerosis	5.45e-06	0.000142	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—APOB—atherosclerosis	5.4e-06	0.000141	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CETP—atherosclerosis	5.38e-06	0.00014	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PPARG—atherosclerosis	5.34e-06	0.000139	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTM1—atherosclerosis	5.3e-06	0.000138	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTM1—atherosclerosis	5.25e-06	0.000137	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—INS—atherosclerosis	5.24e-06	0.000136	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—LPL—atherosclerosis	5.2e-06	0.000135	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—LPL—atherosclerosis	5.16e-06	0.000134	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—SCARB1—atherosclerosis	5.15e-06	0.000134	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GPX1—atherosclerosis	5.07e-06	0.000132	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GPX1—atherosclerosis	5.03e-06	0.000131	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CD36—atherosclerosis	4.94e-06	0.000129	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CD36—atherosclerosis	4.9e-06	0.000128	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.86e-06	0.000127	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALB—atherosclerosis	4.8e-06	0.000125	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MTHFR—atherosclerosis	4.68e-06	0.000122	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.64e-06	0.000121	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PPARA—atherosclerosis	4.59e-06	0.00012	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NOS3—atherosclerosis	4.59e-06	0.00012	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PPARA—atherosclerosis	4.56e-06	0.000119	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AGT—atherosclerosis	4.45e-06	0.000116	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AGT—atherosclerosis	4.41e-06	0.000115	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—APOE—atherosclerosis	4.36e-06	0.000113	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.33e-06	0.000113	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—APOE—atherosclerosis	4.32e-06	0.000112	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CAV1—atherosclerosis	4.32e-06	0.000112	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—APOA1—atherosclerosis	4.31e-06	0.000112	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CAV1—atherosclerosis	4.28e-06	0.000111	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—APOA1—atherosclerosis	4.27e-06	0.000111	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PTGS2—atherosclerosis	4.2e-06	0.000109	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	3.94e-06	0.000102	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.9e-06	0.000102	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PPARG—atherosclerosis	3.8e-06	9.88e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PPARG—atherosclerosis	3.77e-06	9.8e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—INS—atherosclerosis	3.72e-06	9.69e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.72e-06	9.68e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—INS—atherosclerosis	3.69e-06	9.61e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—APOB—atherosclerosis	3.56e-06	9.27e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.46e-06	9.02e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALB—atherosclerosis	3.41e-06	8.89e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—LPL—atherosclerosis	3.4e-06	8.85e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALB—atherosclerosis	3.39e-06	8.81e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GPX1—atherosclerosis	3.32e-06	8.63e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NOS3—atherosclerosis	3.27e-06	8.5e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NOS3—atherosclerosis	3.24e-06	8.43e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CD36—atherosclerosis	3.23e-06	8.41e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.06e-06	7.97e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PPARA—atherosclerosis	3e-06	7.82e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.99e-06	7.77e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.96e-06	7.71e-05	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—AKT1—atherosclerosis	2.92e-06	7.6e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AGT—atherosclerosis	2.91e-06	7.57e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—APOE—atherosclerosis	2.85e-06	7.42e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CAV1—atherosclerosis	2.82e-06	7.35e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—APOA1—atherosclerosis	2.82e-06	7.33e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.57e-06	6.7e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PPARG—atherosclerosis	2.48e-06	6.46e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—INS—atherosclerosis	2.44e-06	6.34e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALB—atherosclerosis	2.23e-06	5.81e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NOS3—atherosclerosis	2.14e-06	5.56e-05	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—AKT1—atherosclerosis	2.11e-06	5.5e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.95e-06	5.08e-05	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.5e-06	3.91e-05	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—AKT1—atherosclerosis	1.49e-06	3.87e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—AKT1—atherosclerosis	9.82e-07	2.55e-05	CbGpPWpGaD
